Article
Early Experiments with Generative AI in a Digital Therapeutic for IBS: Impact on Retention, Therapeutic Alliance, Efficacy, and User Satisfaction
2025-10-22
Abstract excerpt
<p>Background: Digital therapeutics (DTx) offer scalable access to evidence-based care but are constrained by limited personalization, low adherence, and weaker therapeutic alliance compared with in-person care. Nerva, a validated evidence-based brain-gut therapy app for irritable bowel syndrome (IBS), provides a platform to test whether artificial intelligence (AI) can address these barriers. <h4>Methods:</h4> We...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1c7300b0-9a0b-50e0-ae37-f01bcbc92efb
- DOI
- 10.31234/osf.io/yj2xf_v1
